Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03712267 · ClinicalTrials.gov registry record · NA

Electronic Media and Its Application in Psychotherapy

A NA study, sponsored by Mclean Hospital.

Completed
Registry status
NA
Development phase
110
Enrollment target

NCT03712267: Completed NA study, sponsored by Mclean Hospital.

NCT03712267 is a NA study that has completed, run by Mclean Hospital. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03712267, a NA study, has completed, sponsored by Mclean Hospital.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target

Study Summary

This randomized control trial aims to establish whether viewing and discussing patients' electronic communication (texts, emails, Facebook direct messaging, etc) impacts clinical care and decision making across the lifespan.

Primary Outcome

Investigators will use the Short Form Health - 36 Item Survey (SF-36) to assess whether use of electronic media will lead to participants reporting improved functioning/quality of life. The SF-36 is a patient-administered scale and focuses on 8 domains including social functioning, perceptions of health, emotional well-being, role limitations due to physical or emotional concerns, and physical functioning.

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL Electronic Media Enhanced

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2018-12-13
Est. Completion 2023-08-31
Phase NA
Mclean Hospital

140 total trials

What the finished NCT03712267 record still lists

NCT03712267 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT03712267 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03712267 about?

NCT03712267 is a clinical study titled "Electronic Media and Its Application in Psychotherapy". This randomized control trial aims to establish whether viewing and discussing patients' electronic communication (texts, emails, Facebook direct messaging, etc) impacts clinical care and decision making across the lifespan.

What is the current status of trial NCT03712267?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2018-12-13. Estimated completion is 2023-08-31.

What interventions are being tested in trial NCT03712267?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Electronic Media Enhanced (BEHAVIORAL).

Who is sponsoring clinical trial NCT03712267?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03712267's enrollment target sits among peer trials

110 816th of 2000 higher than 1,176 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03712267, the US trial registry maintained by the National Library of Medicine. NCT03712267 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.